Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients.

Catalano, Concetta; SERVAIS, Sophie; BONVOISIN, Catherine; Couturier, Bruno; Hildebrand, Marc; Etienne, Isabelle; MEURIS, Christelle; Goffard, Jean-Christophe; Wissing, Martin; Goldman, Michel; Le Moine, Alain

doi:10.1097/TP.0000000000003942

Download

Article (Scientific journals)

Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients.

Catalano, Concetta; SERVAIS, Sophie; BONVOISIN, Catherine et al.

2021 • In Transplantation, 105, p. 282

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/289552

DOI
10.1097/TP.0000000000003942

PubMed
34456266

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Preemptive_Antibody_Therapy_for_Vaccine.12.pdf

Author postprint (323.87 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Hematology

Author, co-author :

Catalano, Concetta; Hôpital Erasme, Université libre de Bruxelles, Brussel, Belgium

SERVAIS, Sophie ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique

BONVOISIN, Catherine ; Centre Hospitalier Universitaire de Liège - CHU > > Service de néphrologie

Couturier, Bruno; Hôpital Erasme, Université libre de Bruxelles, Brussel, Belgium

Hildebrand, Marc; Hôpital Erasme, Université libre de Bruxelles, Brussel, Belgium

Etienne, Isabelle; Hôpital Erasme, Université libre de Bruxelles, Brussel, Belgium

MEURIS, Christelle ; Centre Hospitalier Universitaire de Liège - CHU > > Service des maladies infectieuses - médecine interne

Goffard, Jean-Christophe; Hôpital Erasme, Université libre de Bruxelles, Brussel, Belgium

Wissing, Martin; Universitair Ziekenhuis Brussel, Brussel, Belgium

Goldman, Michel; I3h Institute, Université libre de Bruxelles, Brussel, Belgium

Le Moine, Alain; Hôpital Erasme, Université libre de Bruxelles, Brussel, Belgium

Language :

English

Title :

Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients.

Publication date :

2021

Journal title :

Transplantation

ISSN :

0041-1337

eISSN :

1534-6080

Publisher :

Lippincott Williams and Wilkins, United States

Volume :

105

Pages :

e282

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 11 April 2022

Statistics

Number of views

54 (7 by ULiège)

Number of downloads

35 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Qin CX, Moore LW, Anjan S, et al. Risk of breakthrough SARSCoV-2 infections in adult transplant recipients. Transplantation. 2021;105:e265-e266.
Kamar N, Abravanel F, Marion O, et al. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385:661-662.
Hall VG, Ferreira VH, Ku T, et al. Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients N Engl Med. 2021;385:1244-1246.
Ollila TA, Lu S, Masel R, et al. Antibody response to COVID-19 in adults with hematologic malignant disease [published online ahead of print August 11, 2021]. JAMA. 2021. doi:10.1001/jamaoncol.2021.4381
Weinreich DM, Sivapalasingam S, Norton T, et al; Trial Investigators. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med. 2021;384:238-251.